Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
- PMID: 25498454
- DOI: 10.1182/blood-2014-10-604272
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
Comment in
-
Response: Additional data needed for a better understanding of the potential relationship between atrial fibrillation and ibrutinib.Blood. 2015 Mar 5;125(10):1673. doi: 10.1182/blood-2015-01-621466. Blood. 2015. PMID: 25745185 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

